![]() |
市場調査レポート
商品コード
1663694
女性不妊手術機器の世界市場 - 市場規模(セグメント別)、シェア、規制、償還、介入、予測(~2036年)Female Sterilization Devices Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 |
||||||
カスタマイズ可能
適宜更新あり
|
女性不妊手術機器の世界市場 - 市場規模(セグメント別)、シェア、規制、償還、介入、予測(~2036年) |
出版日: 2024年12月19日
発行: GlobalData
ページ情報: 英文
納期: 即納可能
![]() |
当レポートでは、世界の女性不妊手術機器市場について調査分析し、各地域の市場規模、主要動向、革新的な製品と技術、競合情勢などの情報を提供しています。
市場モデルの主な内容は以下の通りです。
上市済みの女性不妊手術機器と進化する競合情勢
世界、地域、国レベルの各市場の考察
医療制度の概要を含む真の全体像を把握することで、市場の理解を促進します。また、市場参入セグメントでは、償還政策や規制情勢についての情報を提供し、市場力学をより深く掘り下げることができます。
対象企業
Female Sterilization Devices Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 is built to visualize quantitative and qualitative market trends within Reproductive Health Devices therapeutic area.
Female Sterilization is a permanent procedure where the fallopian tubes are blocked using surgical and non-surgical techniques. The fallopian tubes are blocked to prevent the sperm from fertilizing the egg, thereby preventing the woman from becoming pregnant.
Female sterilization is a permanent procedure where the fallopian tubes are blocked using surgical and non-surgical techniques. Use of female sterilization devices may remain stable (with very low rates of decline/increase) in future with greater educational attainment and income in most of the countries. Reversible methods and male sterilization are increasing in popularity; vasectomy is considered to be safer than female sterilization as there is no increased risk of ectopic pregnancy if vasectomy fails. However, introduction of new and low cost technologies/devices that reduce the risk of STD's, and cause no/less side effects may hinder the tubal clips/rings market to a large extent and may generate new opportunities in the future. Female sterilization does not protect against sexually transmitted diseases, including HIV. Since, these methods are permanent; these are recommended for women who are sure of their decision of not having any children in the future.
Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with intervention volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Female Sterilization Devices and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Utah Medical Products Inc, Gyrus ACMI Inc, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -